Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds.

@article{Lagrue2015LenalidomideAA,
  title={Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds.},
  author={Kathryn Lagrue and Alex Carisey and David J Morgan and Rajesh Chopra and Daniel M. Davis},
  journal={Blood},
  year={2015},
  volume={126 1},
  pages={50-60}
}
As multiple myeloma (MM) progresses, natural killer (NK)-cell responses decline against malignant plasma cells. The immunomodulatory drug lenalidomide is widely used for treatment of MM but its influence on NK-cell biology is unclear. Here, we report that lenalidomide lowers the threshold for NK-cell activation, causing a 66% decrease in the 50% effective concentration (EC50) for activation through CD16, and a 38% decrease in EC50 for NK group 2 member D (NKG2D)-mediated activation, allowing NK… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A.

Proceedings of the National Academy of Sciences of the United States of America • 2014

Similar Papers

Loading similar papers…